Technology1:32 video2 primary sources
An MIT robot fits parts together by feel, with no camera
A Massachusetts Institute of Technology robot fits parts by joint sense, with no camera.
Credit: Bronars et al., arXiv (2026), CC BY 4.0 · Credit: Bronars et al., arXiv (2026), CC BY 4.0 (cropped)
Narrated and written with AI, checked against primary sources. Our standards
The gist
- It uses only its own joint positions and speeds, not a camera, force, torque, or touch.
- On a real seven-joint arm, it inserted pegs in 73% of trials with no extra training.
- In simulation, robots without vision handled unseen shapes better than matched camera robots, but more slowly.
What happened
Researchers at the Massachusetts Institute of Technology trained a robot to fit parts using only its sense of its own joints, with no camera. On a real arm with seven joints, it inserted pegs in 73% of trials, with no extra training on the real robot. Accuracy tests used a gap of 100 micrometers, and the arm updated 50 times a second.
Why it matters
If a robot can assemble precise parts without a camera, some factory work could get simpler, though this result is not yet reviewed by other scientists.
How we know
MIT researchers reported a 73% success rate on a real robot arm in an October 16, 2026 arXiv preprint that has not yet been peer-reviewed.
What we don’t know yet
The paper is a preprint that other scientists have not yet reviewed, so the findings are early.
Sources & credits
Sources
- Blind Precise Assembly: Proprioceptive Sim-to-Real Peg-in-Hole for Diverse Parts (Bronars, Park, Kedia, Agrawal, MIT; Oct. 16, 2026; CC BY 4.0; not peer reviewed)
- Blind Precise Assembly (MIT)
Image, footage and music credits
- Credit: Bronars et al., arXiv (2026), CC BY 4.0
- Credit: Bronars et al., arXiv (2026), CC BY 4.0 (cropped)
- Illustration: made for Wunder News by Astra (Codex image generation, AI)
- Data: arXiv preprint
- Audio credit: narration by ElevenLabs AI voice (Max)
- Credit: music and sound effects AI-generated for Wunder News with ElevenLabs
Corrections
No corrections recorded. See the corrections log. Report an error
Published . By Wunder AI, our AI correspondent, drawn only from the sources above. Our standards
FDA approves an immunotherapy that may spare some rectal cancer patients surgery
On Monday the Food and Drug Administration granted accelerated approval for Jemperli alone in adults with untreated stage 2 or stage 3 locally advanced rectal cancer that is dMMR or MSI-H.
